It's time after a close above the 10 ema on breakout dayWas it on your watch-list (see link to related ideas)?
D1EX34 trade ideas
Another one for the watchlistDon't just buy into the tickers your reading about that are climbing during this correction. Some look horrible at this point, but this really does look like it's ready to break out and climb higher. Watch for a bull flag breakout on good volume.
Trade Journal: Long DXCM - 1/29/2020Markets were showing indecision in direction and my bias for the overall market is still bullish. I wanted to add another long today encase this recent market weakness is just a fake out bounce. I do have one short position as a hedge. I decided to go long this DXCM pennant pattern in the daily. DXCM is at all time highs and recently gapped up and ran due to earnings. The pennant pattern also rest right at a level of support and there are strong candlestick patterns (Hammers) rejecting this support. Furthermore, DXCM is resting at the 20MA which is typically where strong stocks like to bounce.
Entry - 237.76
Stop loss - 321.90
Target 1 - 250
Target 2 - 268
I plan to use the 20MA has my all-out level.
DexCom Inc - Short OpportunityAs a beginner, I'm trying to learn everything I can about investing for the long term, but also trading in the intermediate and short term. With some successes and failures now under the belt I figure I would share my next opportunity.
DexCom's recent earnings release surprised the hell out of analysts, rocketing up 27% on that day and still rising now. Hence, my next short opportunity.
A stock continually pushing a 52 week high has no reference point for resistance, therefore it's best to rely on indicators and the trusty candlestick patterns.
The volume has been dropping steadily since the earnings, pushing into overbought territory it's never seen before. At the sight of a bearish shooting star, with no increase in volume, go short!
Set yourself some reasonable profit margins and stops. Chances are it will test the $185.20 it opened at after earnings, but if you want to be more cautious utilize Fib Retracements (38.2% to 61.8%) from it's peak.
Remember, don't be greedy and lock in profits when you reach your goals.
Dexcom Clearing Resistance (DXCM)Dexcom has made a significant move above resistance, assuming today's gains hold. It is still early, and volume looks good, so if the price stays up it should be a solid volume breakout.
This stock held up well while the market was tanking.
Price target is an estimate (always). I am using a trailing stop loss on this one.
Disclosure: Long.
Dexcom (DXCM) Nears Major Range Breakout LevelDexcom rallied off the lows of the range and is now consolidating near the top of a year-long range.
Watching this one closely. About a 3:1 reward to risk with a stop loss below the consolidation and a target between 196 and 200. Want to see high volume on the consolidation breakout to show there is likely enough conviction to break above the range high as well. Can use ATR Stps as a trailing stop as well; adjust inputs to suit your preferences.
Disclosure: no trade yet, but may initiate within the next few days if the conditions stay favorable.
LONG DXCM High Alpha Momentum RSI Breakout PlayDXCM flirting with new highs while RSI looks pretty constructive. This looks like it might run a bit so while it might be a nice quick momentum play there is probably a lot of long term appeal here. This also applies to AYX which I just posted.
DXCM flagSymbol DXCM
setup flag
Upcoming Earnings Jan 29, 2019 (EST) Feb 21, 2019 (EST)
Horizontal S&R: yes 138
Channel S&R: no
MA S&R: yes bounced off of 20ma
>200ma: yes
Volume confirmation: ok
Candle Confirmation: yes morning star
Stoch Divergence: no
Reg Trendline >85: no
Short Float: 7%
Entry 152
Stop 137
Price Target 182
Risk / Reward: 1:2
Zacks Rank: 2-Buy 2 Style Scores: D Value | A Growth | F Momentum | C VGM Industry Rank: Top 27%(67 out of 255) Industry: Medical - Instruments
Any feedback is welcomed.
DexCom's CGM is the FUTURE.Clearly, that Dec 24 route was the clear buying opportunity, You would've been +40% by now.
Is it too late? I'd say NO.
If you have the ability to invest on this, and of course, have an awareness on all the geopolitical factors. I think this is a win.
If you want to swing, it's also up to you.
Here's the thing
1) Let's be clear, DexCom is the leader on CGM (continuous glucose monitoring). BTW, best presentation on JPM Conference.
2) G6 is being sold to partners like tandem, lily, insulet, and novo, basically eating on their lunch.
FY18 revenue estimate is from $830m to $850m. ($715m the year before). CEO Kevin Sayer expects revenue to exceed $331m
3) Regarding their collaboration with Verily(GOOG), they expect a product with a lower cost;
smaller, longer life, &disposable which benefits those who aren't using CGM yet.
3) The future - There are a lot of people that need to be (and will be) screened, not to mention pre-diabetics.
My take: There's so much room to improve the G6 tech. I'm thinking, insulin delivery system kind of like tandem's t:slim.
That way, they can serve type 2 diabetics.
I like Tandem and I think the collaboration is perfect and I think the Verily product will take the stock higher.
Also, a sensor that goes straight to the Apple Watch $AAPL so the patient doesn't have to carry a phone.
Strategy: Obtain approval to launch G6 globally; Focus on the rollout to Medicare population.
Price Target: Call me crazy but I think DXCM can trade up to Abiomed's level. $320-400. Why?
I think this is a monopoly in CGM, and they can execute globally.
Strong uptrend waiting for a short pullbackThis stock has been strong but is a little bit over extended on the weekly chart. Once it pulls back on the weekly it will be a strong buy.
DXCM
DEXCOM ShortWe can see that, dex com finished his waves and when we look at the rsi we can see the unconformity. Target is 91 dollars.
